Wells Fargo & Company vs Novartis AG
Market cap comparison over time
Wells Fargo & Company
$252.2B
Rank #57
Novartis AG
$259.7B
Rank #55
Market Cap Over Time
Key Moments
- Wells Fargo & Company overtook Novartis AG by 2002
- Novartis AG overtook Wells Fargo & Company by 2019
- Wells Fargo & Company overtook Novartis AG by 2024
- Novartis AG overtook Wells Fargo & Company by 2026
Year-by-Year Comparison
| Year | Wells Fargo & Company | Novartis AG | Leader |
|---|---|---|---|
| 2026 | $252.2B | $259.7B | Novartis AG |
| 2025 | $282.2B | $227.3B | Wells Fargo & Company |
| 2024 | $208.2B | $177.6B | Wells Fargo & Company |
| 2023 | $142.1B | $163.8B | Novartis AG |
| 2022 | $115.6B | $146.3B | Novartis AG |
| 2021 | $131.2B | $134.5B | Novartis AG |
| 2020 | $81.4B | $134.7B | Novartis AG |
| 2019 | $139.6B | $142.4B | Novartis AG |
| 2018 | $114.9B | $110.8B | Wells Fargo & Company |
| 2017 | $147.0B | $104.0B | Wells Fargo & Company |
| 2016 | $129.9B | $89.6B | Wells Fargo & Company |
| 2015 | $124.1B | $100.4B | Wells Fargo & Company |
| 2014 | $121.9B | $103.4B | Wells Fargo & Company |
| 2013 | $98.2B | $76.6B | Wells Fargo & Company |
| 2012 | $71.8B | $59.2B | Wells Fargo & Company |
| 2011 | $56.4B | $52.5B | Wells Fargo & Company |
| 2010 | $62.3B | $51.1B | Wells Fargo & Company |
| 2009 | $53.9B | $50.7B | Wells Fargo & Company |
| 2008 | $57.5B | $44.5B | Wells Fargo & Company |
| 2007 | $56.5B | $50.6B | Wells Fargo & Company |
| 2006 | $64.3B | $55.9B | Wells Fargo & Company |
| 2005 | $55.1B | $53.9B | Wells Fargo & Company |
| 2004 | $52.7B | $43.8B | Wells Fargo & Company |
| 2003 | $48.4B | $42.0B | Wells Fargo & Company |
| 2002 | $37.4B | $36.9B | Wells Fargo & Company |
| 2001 | $33.9B | $43.1B | Novartis AG |
| 2000 | $42.5B | $50.7B | Novartis AG |
| 1999 | $30.2B | $40.7B | Novartis AG |
| 1998 | $29.3B | $46.3B | Novartis AG |
| 1997 | $27.8B | $40.1B | Novartis AG |
| 1996 | $15.3B | $24.5B | Novartis AG |
| 1995 | $11.3B | $16.9B | Novartis AG |